Transactions
G3 Genomics evaluates and acquires assets, product lines and intellectual property in molecular diagnostics and life science tools. We act as a principal, for our own account or with identified partners.
What we acquire
- Product lines, assay content and reagent formulations
- Patent portfolios, trademarks and know-how
- Laboratory and manufacturing equipment
- Customer contracts and distribution relationships
Situations
- Fiduciary-led and court-supervised sale processes
- Lender-led and board-led sale processes
- Corporate carve-outs of non-core product lines
- University and corporate intellectual property that has not been commercialized
Working with sellers and advisers
We participate in sale processes run by owners, boards, lenders and fiduciaries, and by their advisers. We sign NDAs promptly, run focused diligence, deliver written indications of interest and negotiate definitive agreements.
Confidentiality
We do not publicize transactions or the parties involved.
Criteria
- Sectors: Molecular diagnostics, genomics tools and services, research reagents, laboratory operations
- Geography: United States
Submit a transaction
Sellers, lenders and advisers can send a teaser or brief description to [email protected]. We respond within two business days.